Begona Diez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.
Journal: Molecular therapy. Oncology
Published: April 17, 2025
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances.
Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2024
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.
Journal: Lancet (London, England)
Published: March 12, 2024
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I.
Journal: Molecular therapy. Methods & clinical development
Published: December 16, 2021
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Journal: Cell stem cell
Published: November 12, 2018
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients.
Journal: EMBO molecular medicine
Published: September 14, 2017
A novel high-content analysis tool reveals Rab8-driven cytoskeletal reorganization through Rho GTPases, calpain and MT1-MMP.
Journal: Journal of cell science
Published: May 27, 2015
BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice.
Journal: The Journal of pathology
Published: November 28, 2014
Targeted gene therapy and cell reprogramming in Fanconi anemia.
Journal: EMBO molecular medicine
Published: May 27, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026